This Wireless Firm’s $23B Deal Could Be Its Ticket Out of Bankruptcy

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.

When’s the last time you got to see a millionaire trader place a live trade—right in front of you?

On Wednesday, August 27th @ 2 P.M. ET, Nate Bear is going live for the very first 10X Lotto Trade Summit.

During this free event, you’ll discover the strategy he used to turn $37K into $2.7M.

You’ll see how he spots low-cost setups that can turn a couple hundred dollars into thousands.

And most importantly, you’ll watch him place a trade live—so you can see how his process works from start to finish.

This isn’t a theory class.

It’s real-world trading, with real setups, and real opportunity.

If you’ve ever wanted to learn how to potentially turn a tiny stake into a meaningful gain—without risking a fortune—this is your chance.

U.S. stocks edged higher Tuesday as upbeat health care gains and resilient tech strength balanced concerns over Fed independence, with investors turning their focus to Nvidia’s looming earnings.

RTX (NYSE: RTX), through its Pratt & Whitney division, has been awarded a $2.8 billion contract to produce 141 F135 engines that power Lockheed Martin’s (NYSE: LMT) F-35 fighter jets.

The order covers U.S. and allied demand as part of Lot 18 aircraft deliveries, extending Pratt & Whitney’s leadership role in the Joint Strike Fighter program.

For equity holders, the award strengthens RTX’s backlog in its defense business at a time when the commercial aerospace sector is still recovering unevenly and facing supply chain constraints.

With more than 1,300 F135 engines already delivered, the new contract builds on a proven platform, providing long-term cash flow visibility.

This stability helps balance RTX’s earnings profile and reinforces its dividend-supported model.

Those studying the defense sector should view this as a signal of how embedded Pratt & Whitney remains in U.S. and allied military readiness.

While Lockheed captures headlines as the prime contractor, RTX secures recurring value as the exclusive engine supplier, which puts them in a position that competitors cannot easily challenge. 

The award also highlights steady demand for advanced propulsion systems, aligning RTX with multi-decade defense spending commitments.

The contract reinforces RTX’s role as a cornerstone of the U.S. defense industrial base. For shareholders, it adds resilience and predictability to the company’s growth trajectory.

Eli Lilly (NYSE: LLY) reported that its daily obesity pill, orforglipron, met the primary goals of a late-stage trial in patients with obesity and Type 2 diabetes.

The treatment helped participants lose an average of 10.5% of their body weight while also improving blood sugar control, providing Lilly with the complete clinical package needed to begin global regulatory filings for chronic weight management.

For equity holders, the milestone highlights Eli Lilly’s ability to expand its GLP-1 franchise beyond injectable drugs, such as Zepbound.

An oral pill is easier to manufacture and distribute, potentially broadening access and accelerating adoption.

That convenience could translate into higher patient volumes and recurring revenue, supporting the long-term growth trajectory of Lilly’s obesity and diabetes portfolio.

Competitive positioning also matters.

Novo Nordisk is developing its own oral GLP-1, but dietary restrictions and manufacturing challenges leave room for Eli Lilly to capture a near-term advantage.

With GLP-1s already considered one of the most lucrative therapeutic markets, a differentiated oral option strengthens Lilly’s edge in one of the fastest-growing categories in healthcare.

The trial's success reinforces Eli Lilly’s leadership in the innovation of obesity treatment.

For shareholders, it provides visibility into new revenue streams that could reshape the company’s valuation profile in the coming decade.

You don’t need 100 trades to change your future. Sometimes, it only takes five.

Our team filtered through thousands of companies to identify the 5 best positioned for outsized returns.

These stocks were chosen for two reasons:

Past editions of this report uncovered stocks that soared +175%, +498%, even +673%.¹

Now it’s your turn to see the latest 5 hand-picked opportunities.

Why settle for average, when massive is within reach?

Markets love momentum, but even the strongest runs eventually cool.

After a string of blowout quarters, some stocks are now flashing technical warnings that suggest it may be time for investors to trim exposure.

Reddit and Altria fall into that camp where both have delivered outsized gains this year, yet the setup now looks stretched against their fundamentals.

Reddit (NYSE: RDDT)

Reddit has been one of 2025’s standout performers, riding a 121% surge in just three months after reporting 78% year-over-year revenue growth.

Earnings and user engagement trends are undeniably strong, but the stock has moved too far, too fast.

Its RSI has breached the overbought zone twice this month, and the MACD is confirming weakening momentum.

A pullback into the $175–$185 range would not be surprising, especially given how quickly shares moved from $50 to over $220 in just a year.

Altria (NYSE: MO)

Altria isn’t supposed to trade like a growth stock, yet shares have rallied nearly 30% year-to-date.

The push above $66 has sent RSI over 80, a rare event for a defensive dividend payer.

History suggests this kind of move rarely sticks. Even a 10% pullback toward its 50-day moving average would bring valuations back in line with fundamentals.

Reddit and Altria highlight a classic lesson: even strong businesses can become poor buys when technicals outpace reality.

Locking in profits here may be the smarter long-term move.

👉 Click here to get our closing report to your cell for free!

Echostar Corp [SATS] $50.87 (+70.25%)

EchoStar soared after selling $23 billion worth of spectrum to AT&T, giving it enough cash to avoid bankruptcy and pay down debt.

Nukkleus Inc [NUKK] $5.80 (+17.41%)

Nukkleus jumped after launching a new defense subsidiary and securing exclusive U.S. rights to BladeRanger’s drone payload tech.

Ranpak Holdings Corp [PACK] $5.57 (+15.32%)

Ranpak gained after Walmart expanded its use of the company’s AI-powered AutoFill packaging systems across five major fulfillment centers.

Laser Photonics Corp [LASE] $5.52 (-15.21%)

Laser Photonics dipped after delaying its Q2 report filing, citing difficulties in compiling necessary financial data, though it expects no material changes.

Transcat Inc [TRNS] $81.93 (-10.16%)

Transcat fell nearly 9% after announcing that longtime CEO Lee Rudow will retire in 2026, introducing uncertainty around future leadership.

EHang Holdings Ltd [EH] $16.45 (-7.53%)

EHang plunged after slashing its 2025 revenue forecast by 45%, prompting Morgan Stanley to lower delivery estimates and price target.

Market volatility, policy shifts, and economic tension are leaving many investors overwhelmed.

But buried under the chaos are clear signals of opportunity — if you know where to look.

That’s why we created a free, exclusive guide highlighting 7 stocks positioned for growth as 2025 progresses.

Even in uncertain times, preparation separates winners from watchers.

Download your copy today and get one step closer to smarter, faster trades.

[Claim your free report now]

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.